99 related articles for article (PubMed ID: 8333036)
1. The in vivo and in vitro effect of 15-deoxyspergualin on pancreatic islet function.
Xenos ES; Casanova D; Sutherland DE; Farney AC; Lloveras JJ; Gores PF
Transplantation; 1993 Jul; 56(1):144-7. PubMed ID: 8333036
[TBL] [Abstract][Full Text] [Related]
2. Deoxyspergualin is a unique immunosuppressive agent with selective utility in inducing tolerance to pancreas islet xenografts.
Thomas F; Pittman K; Ljung T; Cekada E
Transplant Proc; 1995 Feb; 27(1):417-9. PubMed ID: 7879045
[TBL] [Abstract][Full Text] [Related]
3. [Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation].
Ueno M; Nakajima Y; Kanehiro H; Yoshimura A; Nakano H
Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):376-82. PubMed ID: 7686615
[TBL] [Abstract][Full Text] [Related]
4. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets.
Ishizuka J; Gugliuzza KK; Wassmuth Z; Hsieh J; Sato K; Tsuchiya T; Townsend CM; Fish JC; Thompson JC
Transplantation; 1993 Dec; 56(6):1486-90. PubMed ID: 7506454
[TBL] [Abstract][Full Text] [Related]
5. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
Hyder A; Laue C; Schrezenmeir J
Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxyspergualin attenuates pericapsular cellular infiltration and prolongs survival of alginate-poly-L-lysine-alginate microencapsulated islets.
Hsu BR; Fu SH; Hsueh C; Tsai JS; Huang YY; Huang HS
Transplant Proc; 1997 Jun; 29(4):2158-60. PubMed ID: 9193570
[No Abstract] [Full Text] [Related]
7. Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells.
Polastri L; Galbiati F; Bertuzzi F; Fiorina P; Nano R; Gregori S; Aldrighetti L; Pozza G; Secchi A; Adorini L; Davalli AM
Acta Diabetol; 2002 Dec; 39(4):229-33. PubMed ID: 12486498
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets.
Paty BW; Harmon JS; Marsh CL; Robertson RP
Transplantation; 2002 Feb; 73(3):353-7. PubMed ID: 11884930
[TBL] [Abstract][Full Text] [Related]
9. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass.
Kaufman DB; Gores PF; Field MJ; Farney AC; Gruber SA; Stephanian E; Sutherland DE
Diabetes; 1994 Jun; 43(6):778-83. PubMed ID: 8194663
[TBL] [Abstract][Full Text] [Related]
10. The rescue effect of 15-deoxyspergualin on intraperitoneal microencapsulated xenoislets.
Hsu BR; Chang FH; Juang JH; Huang YY; Fu SH
Cell Transplant; 1999; 8(3):307-15. PubMed ID: 10442743
[TBL] [Abstract][Full Text] [Related]
11. Effect of the immunosuppressant FK 506 on insulin release from adult rat islets of Langerhans.
Carroll PB; Gonçalves AA; Boschero AC; Tzakis AG; Starzl TE; Atwater I
Transplant Proc; 1991 Feb; 23(1 Pt 1):337-9. PubMed ID: 1703688
[No Abstract] [Full Text] [Related]
12. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats.
Ar'Rajab A; Ahrén B
Eur J Pharmacol; 1991 Jan; 192(3):443-5. PubMed ID: 2055243
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
[TBL] [Abstract][Full Text] [Related]
14. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets.
Johnson JD; Ao Z; Ao P; Li H; Dai LJ; He Z; Tee M; Potter KJ; Klimek AM; Meloche RM; Thompson DM; Verchere CB; Warnock GL
Cell Transplant; 2009; 18(8):833-45. PubMed ID: 19500470
[TBL] [Abstract][Full Text] [Related]
15. Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets.
Nagamatsu S; Carroll RJ; Grodsky GM; Steiner DF
Diabetes; 1990 Jul; 39(7):871-4. PubMed ID: 2191889
[TBL] [Abstract][Full Text] [Related]
16. Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells.
Tagmose TM; Mogensen JP; Agerholm PC; Arkhammar PO; Wahl P; Worsaae A; Hansen JB
Bioorg Med Chem Lett; 2001 Jul; 11(13):1749-52. PubMed ID: 11425552
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of canine islet allograft survival by 15-deoxyspergualin.
Stephanian E; Lloveras JJ; Sutherland DE; Farney AC; Field MJ; Kaufman DB; Matteson BD; Gores PF
J Surg Res; 1992 Jun; 52(6):621-4. PubMed ID: 1528039
[TBL] [Abstract][Full Text] [Related]
18. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
19. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells.
Verchere CB; D'Alessio DA; Prigeon RL; Hull RL; Kahn SE
Diabetes; 2000 Sep; 49(9):1477-84. PubMed ID: 10969831
[TBL] [Abstract][Full Text] [Related]
20. Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans.
Carroll PB; Boschero AC; Li MY; Tzakis AG; Starzl TE; Atwater I
Transplantation; 1991 Jan; 51(1):275-8. PubMed ID: 1702911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
